US Patent 12077802 Metabolic engineering of

Is a

Patent

Patent attributes

Patent Applicant

InMed Pharmaceuticals

Current Assignee

InMed Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

120778020

Patent Inventor Names

Vikramaditya G. Yadav0

Sandip V. Pawar0

Steven J. Hallam0

Sarvesh K. Srivastava0

Sonal R. Ayakar0

Sazzad Hossain0

Protiva R. Roy0

Date of Patent

September 3, 2024

Patent Application Number

166444840

Date Filed

September 5, 2018

Patent Citations

‌

US Patent 9526715 Chemical engineering processes and apparatus for the synthesis of compounds

‌

US Patent 9359625 Chemical engineering processes and apparatus for the synthesis of compounds

‌

US Patent 9394512 Method for growing mycological materials

‌

US Patent 9512391 Apparatus and methods for biosynthetic production of cannabinoids

‌

US Patent 9587212 Apparatus and methods for biosynthetic production of cannabinoids

Patent Primary Examiner

CPC Code

...

Patent abstract

Provided herein are methods and compositions for producing terpenoids in a host cell. In some cases, the terpenoids are cannabinoids.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 12077802 Metabolic engineering of

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 12077802 Metabolic engineering of